Concord Financial News

25.09 / 08:29

Investment trusts Acquisition Concord Takeover Round Hill Music sets out full terms of takeover scheme

In an RNS release today (25 September) the board outlined the full details of the offer along with a timeline of events if all goes according to plan.

19.10 / 07:41

Investment trusts Acquisition Concord Takeover Round Hill Music shareholders give green light to $469m Concord takeover

The scheme will now need to be sanctioned by the court, which is expected to take place on 30 October 2023.

14.09 / 11:09

Investment trusts continuation vote Hipgnosis Songs Fund Concord Hipgnosis Hipgnosis agrees $465m catalogue sale from public trust to private Blackstone vehicle

The purchase price of the sale of catalogues to Hipgnosis Songs Capital realises a total return of 44%.

21.08 / 06:51

Lowe's show Concord share price Updates Concord Biotech share price Today Live Updates : Concord Biotech Soars in Trading Today

₹939.9 and the close price was ₹941.85. The stock reached a high of ₹942.8 and a low of ₹921.1. The market capitalization is currently at 0.0 crore.

18.08 / 06:07

IPO Target Digital Booking band Concord Premium share price Concord Biotech share price extends gain after listing at 21% premium. Buy, sell or hold?

₹900 apiece on both NSE and BSE, delivering over 21 per cent listing premium to the lucky allottees. The book build issue was offered at a price band of ₹705 to ₹741 per equity share and the issue had received strong response by investors as well. However, the newly listed stock surprised market observers further by extending its listing premium further.

18.08 / 05:11

IPO Booking Citigroup band Concord Premium Concord Biotech shares make stellar debut; list with 21% premium at ₹900 apiece on BSE

₹900.05 apiece on the BSE, as compared to the issue price of Rs 741 per share. Concord Biotech listing on NSE took place at ₹900.05 per share, a premium of 21.46 to the issue price. Concord Biotech IPO had received strong interest from investors as the public issue was subscribed by a robust 24.87 times in total during the IPO subscription period.

18.08 / 02:09

UPS NIFTY Indus Concord Stocks in news: Nykaa, HDFC AMC, Concord Biotech, JSW Steel, Adani Energy

Nykaa, HDFC AMC, Indus Towers, Page Industries, ACCNykaa, HDFC AMC, Indus Towers, Page Industries and ACC have been excluded from Nifty Next50 in the latest revision of various NSE indices.Yatharth HospitalYatharth Hospital reported 73% year-on-year growth in its consolidated net profit at Rs 19 crore for the quarter ended June.Read more: What changed the market while you were sleepingConcord BiotechThe shares of Concord Biotech will debut on the exchanges today.

18.08 / 01:33

IPO band track Concord Concord Biotech IPO listing date today. GMP, experts see moderate debut of shares

Concord Biotech IPO: Listing date of the Indian Public Offering (IPO) of Concord Biotech Limited has been fixed on 18th August 2023 i.e. today. As per the BSE notice, effective from Friday, August 18, 2023, the equity shares of Concord Biotech Limited shall be listed and admitted to dealings on the exchange in the list of 'B' group of securities.

17.08 / 07:39

IPO Booking Citigroup band Concord Concord Biotech IPO: What does GMP signal about the listing?

IPO listing date has been fixed as August 18. The initial public offering (IPO) of Rekha Jhunjhunwala-backed Concord Biotech received strong interest from investors as the public issue was subscribed by a robust 24.87 times in total during the IPO subscription period of August 4 to August 8. The Concord Biotech IPO allotment was finalised on August 11 and the shares are being credited to eligible investors’ demat account today, August 17.

14.08 / 08:15

IPO Booking Citigroup band Concord Concord Biotech IPO: What does GMP signal as focus shifts to listing date; Check key details here

allotment was finalised on August 11, the focus now shifts to the IPO listing date. Concord Biotech share listing is expected to take place on August 18, Friday, on BSE and NSE. However, ahead of the listing, let us take a look at the Concord Biotech IPO GMP, or grey market premium.

11.08 / 13:37

UPS IPO Booking band show Concord Concord Biotech IPO allotment today; Latest, GMP, here's how to check allotment status

IPO listing date has been fixed for Friday, August 18 on NSE and BSE. If you applied for the shares, here's how you can check allotment status of Concord Biotech IPO. If you have applied for the Concord Biotech IPO, you can check your Concord Biotech IPO allotment status immediately on the website of the IPO registrar, Link Intime India Private Ltd.

11.08 / 09:01

IPO Booking Manufacturing Citigroup band country Concord Concord Biotech IPO share allotment likely today. Here's how you can check status

Concord Biotech IPO will likely be finalised on August 11. Investors will get shares on a lottery basis and the whole process will be supervised by the registrar. On the allotment date, investors get to know about the number of shares allotted to them as against the bids made.

11.08 / 03:37

IPO Concord Concord Biotech IPO allotment date likely today. GMP, how to check allotment status online

Concord Biotech IPO: Allotment of shares to the bidders of initial public offering (IPO) of Concord Biotech Limited can be announced any time today. As per the tentative schedule, most likely Concord Biotech IPO allotment date is 11th August 2023 i.e. today.

10.08 / 01:05

UPS IPO band show Concord Concord Biotech IPO allotment tomorrow: Latest GMP, here's how to check allotment status

09.08 / 10:29

IPO Booking Citigroup band Concord Concord Biotech IPO: What does GMP signal as focus shifts to allotment; check key details here

IPO subscription status can be seen as the issue received total bids for 36.42 crore equity shares as against 1.46 crore shares on the offer. The finalisation of Concord Biotech IPO allotment is expected to take place on August 11, while refunds will be initiated on August 14. The shares will be credited to the demat accounts of eligible investors on August 17.

08.08 / 11:35

IPO Booking Assurant Citigroup HSBC band Concord Concord Biotech IPO Day 3: Issue subscribed over 24 times on last day; QIB portion booked 68x

IPO Subscription Status: The initial public offering (IPO) of Concord Biotech Limited has been subscribed 24.79 times in total so far on August 8, the third and final day of the bidding process. The public issue of late ace investor Rakesh Jhunjhunwala’s RARE Trusts-backed biotechnology company received bids for 36.31 crore equity shares as against 1.46 crore shares on the offer. Concord Biotech IPO’s retail category was booked 3.64 times, while the Non-Institutional Investors (NII) category was subscribed 16.95 times.

08.08 / 05:33

IPO Booking band Concord NOT Concord Biotech IPO closes today: Latest GMP, subscription status, review, other details. Apply or not?

Concord Biotech IPO: The initial public offering (IPO) opened for bidding on 4th August 2023 and its subscription will end on 8th August 2023. This means, today is the last date to apply for the public offer of this Rekha Jhunjhunwala-backed company. However, after trend reversal on Dalal Street and strong Concord Biotech IPO subscription status, grey market has gone highly bullish on the public issue.

08.08 / 01:13

UPS IPO Enterprise Metro Matrix star Concord Another Jhunjhunwala long bet blooms with Concord Biotech offer

Concord Biotech launched its IPO Friday, joining the ranks of the late billionaire's other private investment portfolio companies such as Star Health, Metro Brands and Nazara Technologies that have gone public in the past couple of years. The ace investor often called India's Warren Buffet, first invested in Concord in 2004 and later helped the company's founder in buying back the company from pharma major Mylan in 2009.

07.08 / 08:05

IPO Booking Assurant Citigroup HSBC band Concord Concord Biotech IPO Day 2: Issue fully subscribed on day 2; retail portion booked 1.58x

IPO Subscription Status: The initial public offering (IPO) of Concord Biotech Limited has been fully subscribed on day 2 as it received strong demand from retail as well as non-institutional investors. The Concord Biotech IPO so far has been subscribed 1.48 times in total as the issue received bids for 2.16 crore equity shares as against 1.46 crore shares on the offer on August 7, the second day of the bidding process. The public issue received 1.58 times subscription in the retail category and 3.06 times in the Non-Institutional Investors (NII) category.

07.08 / 07:43

UPS IPO Provident Pool Enterprise band country Concord SBFC Finance IPO versus Concord Biotech IPO: Which one should you choose?

Cyient DLM. Given that the two businesses are from two different sector, where SBFC Finance IPO is a non-banking finance company (NBFC), while Concord Biotech IPO is a research & development biopharma company, most analysts are bullish on both. In case you are an investor who is looking to apply for only one, here are some expert views: Speaking on SBFC Finance IPO vs Concord Biotech IPO, Vaibhav Kaushik, Research Analyst at GCL Broking said, “If you ask me to choose either of the two public issues, I would advice investors to go for SBFC Finance IPO as it is providing better valuation comfort to investors.

07.08 / 05:19

UPS IPO Booking Manufacturing Enterprise band Concord SBFC Finance vs Concord Biotech: Which IPO should you pick?

SBFC Finance and Concord Biotech, currently open for subscription. While both the issues have received thumbs-up from analysts, they clearly prefer SBFC Finance over the other if investors had to pick one.SBFC Finance IPO, which closes on Monday, is reasonably priced, offering room to investors for healthy listing gains. The unlisted market trends validate the reasoning as the GMP for the company's shares is around Rs 38, as against the upper price band of 57.

what you should know about Concord

What is Concord and why is it relevant?

Concord is a trending topic that draws public attention. On our site, we regularly publish articles related to this subject.

Where can I find the latest updates on Concord?

All new posts about Concord can be found in the special selection. We publish information in a timely manner.

How can I verify the accuracy of information on Concord?

We rely on trusted sources to ensure that the information about Concord is accurate and valuable for our readers.